2 weeks Ago By Defense World Staff
Bokf Na boosted its holdings in shares of Haleon plc ( NYSE:HLN – Free Report ) by 68.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,972 shares of the company’s stock after buying an additional 2,842 shares during the period.
Bokf Na’s holdings in Haleon were worth $58,000 as of its most recent filing with the Securities and Exchange Commission. Several other large investors have also recently bought and sold shares of the business. Clearbridge Investments LLC raised its position in Haleon by 44.
6% during the first quarter. Clearbridge Investments LLC now owns 38,446,978 shares of the company’s stock valued at $326,415,000 after buying an additional 11,865,076 shares during the period. Wellington Management Group LLP increased its position in Haleon by 164.
6% in the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after purchasing an additional 8,423,475 shares during the last quarter. Douglas Lane & Associates LLC increased its position in Haleon by 1.
6% in the 2nd quarter. Douglas Lane & Associates LLC now owns 8,533,768 shares of the company’s stock worth $70,489,000 after purchasing an additional 131,892 shares during the last quarter. Goldman Sachs Group Inc.
increased its position in Haleon by 19.1% in the 4th quarter. Goldman Sachs Group Inc.
now owns 4,813,997 shares of the company’s stock worth $39,619,000 after purchasing an additional 772,829 shares during the last quarter. Finally, Martin Investment Management LLC increased its position in Haleon by 12,018.4% in the 1st quarter.
Martin Investment Management LLC now owns 4,463,205 shares of the company’s stock worth $37,893,000 after purchasing an additional 4,426,375 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In Several research analysts have weighed in on HLN shares. The Goldman Sachs Group lowered Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Berenberg Bank started coverage on Haleon in a research report on Tuesday, August 6th.
They issued a “buy” rating on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.
Haleon Stock Performance HLN opened at $10.65 on Wednesday. The company has a market cap of $48.
61 billion, a PE ratio of 35.48, a price-to-earnings-growth ratio of 3.10 and a beta of 0.
26. The stock has a 50-day moving average of $9.62 and a 200-day moving average of $8.
82. Haleon plc has a 52-week low of $7.70 and a 52-week high of $10.
66. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.
58 and a current ratio of 0.84. Haleon ( NYSE:HLN – Get Free Report ) last released its quarterly earnings results on Thursday, August 1st.
The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.
01). The company had revenue of $3.50 billion for the quarter, compared to the consensus estimate of $3.
55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.
71%. During the same quarter last year, the company posted $0.08 EPS.
As a group, equities research analysts forecast that Haleon plc will post 0.46 earnings per share for the current fiscal year. Haleon Cuts Dividend The business also recently declared a semi-annual dividend, which will be paid on Thursday, September 19th.
Stockholders of record on Friday, August 16th will be paid a dividend of $0.0514 per share. The ex-dividend date is Friday, August 16th.
This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio (DPR) is presently 33.
33%. About Haleon ( Free Report ) Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also Five stocks we like better than Haleon Investing in Construction Stocks Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion? What is Short Interest? How to Use It Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge Best Stocks Under $5.00 Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc ( NYSE:HLN – Free Report ).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter ..
